135 Results

Nucala receives positive CHMP opinion for new self-administration options.

 Added 13 days ago

GlaxoSmithKline announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive...

Phase III QUARTZ study of inhaled QMF 149 meets endpoints in asthma.

 Added 19 days ago

Novartis announced the first study results from the phase III PLATINUM clinical development program assessing the safety and efficacy of...

Phase II data annonuced for once-daily, fixed dose combination asthma treatment

 Added 27 days ago

Novartis announced that new phase II data for IND/GLY/MF (QVM 149), an investigational, once-daily, fixed dose combination asthma treatment containing...

AstraZeneca reports data from Novel START trial of Symbicort Turbuhaler to relieve inflammation in mild asthma

 Added 28 days ago

New data from Novel START, an open-label trial designed to reflect real-world practice , has demonstrated the effectiveness of Symbicort...

ATS 2019 | Learn more

 Added 1 month ago

ATS 2019 | Learn more

US District Court decides that Vectura's US patent 8303991 was found valid and infringed by US sales of three of GSK Ellipta products.

 Added 1 month ago

Vectura Group plc confirms that on 3rd May 2019 following a jury trial in the United States District Court for...

EU approves Dupixent for severe asthma

 Added 1 month ago

The European Commission has approved Dupixent (dupilumab), from Sanofi, for use in adults and adolescents 12 years and older as...

Phase III CAPTAIN study of Trelegy Ellipta meets primary endpoint in asthma

 Added 1 month ago

GlaxoSmithKline and Innoviva announced headline results from the pivotal phase III CAPTAIN study of once-daily single inhaler triple therapy Trelegy...

CHMP recommends approval for Dupixent for add-on maintenance treatment for severe asthma

 Added 3 months ago

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent (dupilumab),...

FDA approves first generic Advair Diskus to treat asthma and COPD.- Mylan

 Added 4 months ago

The FDA has approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment...

Load more